Literature DB >> 28435160

Anti-CYP4Z1 autoantibodies detected in breast cancer patients.

Venkatrao Nunna1, Nasir Jalal1, Matthias Bureik1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28435160      PMCID： PMC5518819          DOI： 10.1038/cmi.2017.21

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  9 in total

Review 1.  Cytochrome P450 systems--biological variations of electron transport chains.

Authors:  Frank Hannemann; Andreas Bichet; Kerstin M Ewen; Rita Bernhardt
Journal:  Biochim Biophys Acta       Date:  2006-08-02

2.  Combinatorial synthesis of peptide arrays with a laser printer.

Authors:  Volker Stadler; Thomas Felgenhauer; Mario Beyer; Simon Fernandez; Klaus Leibe; Stefan Güttler; Martin Gröning; Kai König; Gloria Torralba; Michael Hausmann; Volker Lindenstruth; Alexander Nesterov; Ines Block; Rüdiger Pipkorn; Annemarie Poustka; F Ralf Bischoff; Frank Breitling
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

3.  Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers.

Authors:  Diane Downie; Morag C E McFadyen; Patrick H Rooney; Margaret E Cruickshank; David E Parkin; Iain D Miller; Colin Telfer; William T Melvin; Graeme I Murray
Journal:  Clin Cancer Res       Date:  2005-10-15       Impact factor: 12.531

Review 4.  CYP4Z1 - A Human Cytochrome P450 Enzyme that Might Hold the Key to Curing Breast Cancer.

Authors:  Xu Yang; Michael Hutter; Wilson Wen Bin Goh; Matthias Bureik
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

5.  21-Hydroxylase, a major autoantigen in idiopathic Addison's disease.

Authors:  O Winqvist; F A Karlsson; O Kämpe
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

6.  Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview.

Authors:  G N. Dalekos; K Zachou; C Liaskos; N Gatselis
Journal:  Eur J Intern Med       Date:  2002-08       Impact factor: 4.487

7.  Human CYP4Z1 catalyzes the in-chain hydroxylation of lauric acid and myristic acid.

Authors:  Andy Zöllner; Calin-Aurel Dragan; Dominik Pistorius; Rolf Müller; Helge B Bode; Frank T Peters; Hans H Maurer; Matthias Bureik
Journal:  Biol Chem       Date:  2009-04       Impact factor: 3.915

8.  Identification of a novel mammary-restricted cytochrome P450, CYP4Z1, with overexpression in breast carcinoma.

Authors:  Michael A Rieger; Reinhard Ebner; David R Bell; Andrea Kiessling; Jacques Rohayem; Marc Schmitz; Achim Temme; E Peter Rieber; Bernd Weigle
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

Review 9.  Autoimmune liver serology: current diagnostic and clinical challenges.

Authors:  Dimitrios-P Bogdanos; Pietro Invernizzi; Ian-R Mackay; Diego Vergani
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742
  9 in total
  9 in total

1.  Screening of cytochrome 4Z1 expression in human non-neoplastic, pre-neoplastic and neoplastic tissues.

Authors:  Yousef M Al-Saraireh; Nafea S Alboaisa; Hamzeh Mohammad Alrawashdeh; Omar Hamdan; Sameeh Al-Sarayreh; Jehad M Al-Shuneigat; Mohammad N Nofal
Journal:  Ecancermedicalscience       Date:  2020-09-29

2.  Expression and Functional Characterization of Breast Cancer-Associated Cytochrome P450 4Z1 in Saccharomyces cerevisiae.

Authors:  Matthew G McDonald; Sutapa Ray; Clara J Amorosi; Katherine A Sitko; John P Kowalski; Lorela Paco; Abhinav Nath; Byron Gallis; Rheem A Totah; Maitreya J Dunham; Douglas M Fowler; Allan E Rettie
Journal:  Drug Metab Dispos       Date:  2017-10-10       Impact factor: 3.922

3.  Cytochrome 4Z1 Expression Is Correlated with Poor Prognosis in Patients with Cervical Cancer.

Authors:  Yousef M Al-Saraireh; Fatemah O F O Alshammari; Ahmed M M Youssef; Yahya M Al-Sarayra; Renata A Al-Saraireh; Ghadeer H Al-Muhaisen; Yanal S Al-Mahdy; Ahlam M Al-Kharabsheh; Seham M Abufraijeh; Hamzeh Mohammad Alrawashdeh
Journal:  Curr Oncol       Date:  2021-09-16       Impact factor: 3.677

4.  Cytochrome 4Z1 Expression is Associated with Poor Prognosis in Colon Cancer Patients.

Authors:  Yousef M Al-Saraireh; Fatemah O F O Alshammari; Ahmed M M Youssef; Sameeh Al-Sarayreh; Ghadeer H Almuhaisen; Nedal Alnawaiseh; Jehad M Al-Shuneigat; Hamzeh M Alrawashdeh
Journal:  Onco Targets Ther       Date:  2021-11-12       Impact factor: 4.147

5.  Cytochrome 4Z1 Expression is Associated with Unfavorable Survival in Triple-Negative Breast Cancers.

Authors:  Yousef M Al-Saraireh; Fatemah O F O Alshammari; Ahmed M M Youssef; Fatima Al-Tarawneh; Sameeh Al-Sarayreh; Ghadeer H Almuhaisen; Anas O Satari; Jehad Al-Shuneigat; Hamzeh Mohammad Alrawashdeh
Journal:  Breast Cancer (Dove Med Press)       Date:  2021-10-05

6.  Cytochrome 4Z1 Expression Connotes Unfavorable Prognosis in Ovarian Cancers.

Authors:  Yousef M Al-Saraireh; Fatemah O F O Alshammari; Anas O Satari; Yanal S Al-Mahdy; Ghadeer H Almuhaisen; Omar H Abu-Azzam; Ala N Uwais; Seham M Abufraijeh; Ahlam M Al-Kharabsheh; Sa'ed M Al-Dalain; Aiman Al-Qtaitat; Fatima Al-Tarawneh; Jehad M Al Shuneigat; Sameeh A Al-Sarayreh
Journal:  Medicina (Kaunas)       Date:  2022-09-13       Impact factor: 2.948

Review 7.  Intratumoural Cytochrome P450 Expression in Breast Cancer: Impact on Standard of Care Treatment and New Efforts to Develop Tumour-Selective Therapies.

Authors:  Smarakan Sneha; Simon C Baker; Andrew Green; Sarah Storr; Radhika Aiyappa; Stewart Martin; Klaus Pors
Journal:  Biomedicines       Date:  2021-03-12

Review 8.  Autoantibodies as Potential Biomarkers in Breast Cancer.

Authors:  Jingyi Qiu; Bailey Keyser; Zuan-Tao Lin; Tianfu Wu
Journal:  Biosensors (Basel)       Date:  2018-07-13

9.  Profiling of CYP4Z1 and CYP1B1 expression in bladder cancers.

Authors:  Yousef M Al-Saraireh; Fatemah O F O Alshammari; Ahmed M M Youssef; Sameeh Al-Sarayreh; Ghadeer H Almuhaisen; Nedal Alnawaiseh; Jehad M Al Shuneigat; Hamzeh M Alrawashdeh
Journal:  Sci Rep       Date:  2021-03-10       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.